Role of miR-143 targeting KRAS in colorectal tumorigenesis
X Chen,X Guo,H Zhang,Y Xiang,J Chen,Y Yin,X Cai,K Wang,G Wang,Y Ba,L Zhu,J Wang,R Yang,Y Zhang,Z Ren,K Zen,J Zhang,C-Y Zhang
DOI: https://doi.org/10.1038/onc.2008.474
IF: 8.756
2009-01-12
Oncogene
Abstract:Dysregulated expression of microRNAs (miRNAs) is associated with a variety of diseases, including colorectal cancer. By comparing more than 200 miRNAs in 13 pairs of matched colorectal cancer and normal adjacent tissue samples through qRT-PCR and microarray analysis, we found a widespread disruption of miRNA expression during colorectal tumorigenesis. In particular, among a panel of presumed targets generated by in silico analysis that may interact with these aberrantly expressed miRNAs, KRAS oncogene has been further experimentally validated as the target of miR-143. First, an inverse correlation between KRAS protein and miR-143 in vivo was found. Second, KRAS expression in Lovo cells was significantly abolished by treatment with miR-143 mimic, whereas miR-143 inhibitor increased KRAS protein level. Third, luciferase reporter assay confirmed that miR-143 directly recognize the 3′-untranslated region of KRAS transcripts. Four, Lovo cells treated with miR-143 inhibitor showed a stimulated cell proliferation, whereas miR-143 overexpression had an opposite effect. Finally, inhibition of KRAS expression by miR-143 inhibits constitutive phosphorylation of ERK1/2. Taken together, the present study provides the first evidences that miR-143 is significant in suppressing colorectal cancer cell growth through inhibition of KRAS translation.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology